Rapid Therapeutic Science Lab inc
Rapid Therapeutic Science Laboratories, Inc. focuses on developing potential commercial opportunities which involve the rapid application of therapeutics using inhaler technology. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013… Read more
Market Cap & Net Worth: Rapid Therapeutic Science Lab inc (RTSL)
Rapid Therapeutic Science Lab inc (PINK:RTSL) has a market capitalization of $151.90K ($151.90K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #41862 globally and #13599 in its home market, demonstrating a 60.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Rapid Therapeutic Science Lab inc's stock price $0.01 by its total outstanding shares 18986917 (18.99 Million).
Rapid Therapeutic Science Lab inc Market Cap History: 2017 to 2025
Rapid Therapeutic Science Lab inc's market capitalization history from 2017 to 2025. Data shows change from $279.35 Million to $151.90K (-66.13% CAGR).
Rapid Therapeutic Science Lab inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Rapid Therapeutic Science Lab inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
222225.15x
Rapid Therapeutic Science Lab inc's market cap is 222225.15 times its annual revenue
0.00x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $147.15 Million | $9.14K | -$348.84K | 16101.17x | N/A |
| 2021 | $118.67 Million | $534.00 | -$4.20 Million | 222225.15x | N/A |
Competitor Companies of RTSL by Market Capitalization
Companies near Rapid Therapeutic Science Lab inc in the global market cap rankings as of March 19, 2026.
Key companies related to Rapid Therapeutic Science Lab inc by market ranking:
- CLUS (PINK:CLUS): Ranked #1958 globally with a market cap of $8.00 Billion USD.
- Cartesian Growth Corporation II Warrant (NASDAQ:RENEW): Ranked #8543 globally with a market cap of $736.93 Million USD.
- Nh Special Purpose Acquisition 14 Co. Ltd (KQ:319400): Ranked #8998 globally with a market cap of $660.01 Million USD ( ₩966.39 Billion KRW).
- EQV Ventures Acquisition Corp. II (NYSE:EVAC): Ranked #10627 globally with a market cap of $465.51 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1958 | CLUS | PINK:CLUS | $8.00 Billion | $200.00 |
| #8543 | Cartesian Growth Corporation II Warrant | NASDAQ:RENEW | $736.93 Million | $138.87 |
| #8998 | Nh Special Purpose Acquisition 14 Co. Ltd | KQ:319400 | $660.01 Million | ₩30900.00 |
| #10627 | EQV Ventures Acquisition Corp. II | NYSE:EVAC | $465.51 Million | $10.07 |
Rapid Therapeutic Science Lab inc Historical Marketcap From 2017 to 2025
Between 2017 and today, Rapid Therapeutic Science Lab inc's market cap moved from $279.35 Million to $ 151.90K, with a yearly change of -66.13%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $151.90K | +700.00% |
| 2024 | $18.99K | -75.00% |
| 2023 | $75.95K | -99.47% |
| 2022 | $14.24 Million | -88.00% |
| 2021 | $118.67 Million | -66.67% |
| 2020 | $356.00 Million | +141.94% |
| 2019 | $147.15 Million | -22.50% |
| 2018 | $189.87 Million | -32.03% |
| 2017 | $279.35 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Rapid Therapeutic Science Lab inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $151.90K USD |
| MoneyControl | $151.90K USD |
| MarketWatch | $151.90K USD |
| marketcap.company | $151.90K USD |
| Reuters | $151.90K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.